Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Study Says Mothers’ Cardiovascular Health Is Linked to Pregnancy Outcomes in Lupus

Ruth Jessen Hickman, MD  |  Issue: October 2019  |  October 18, 2019

MIKHAIL GRACHIKOV / shutterstock.com

MIKHAIL GRACHIKOV / shutterstock.com

A recent study in The Journal of Rheumatology sheds light on the importance of preconceptional cardiovascular health in women with systemic lupus erythematosus. Although many questions remain, improved cardiovascular health measures seem to positively affect pregnancy outcomes, suggesting a potential role for preconception cardiovascular interventions.1

Women with lupus now have healthier pregnancies than in the past, but pregnancy still poses an increased risk for certain problems for mother and child, including preeclampsia, postpartum infection, thrombo­embolic disease, spontaneous abortion and issues resulting from preterm delivery and small-for-gestational-age infants.2 Estimates of the prevalence of infants born preterm or small-for-gestational age put the risk at two to six times higher in lupus patients than in the general population.1

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Women with lupus are also at a fivefold increased risk of significant cardiovascular events than those without the disease.3  The cardiovascular risk factors of hyper­tension, dyslipidemia and obesity appear to be relatively common comorbidities in lupus patients and may be more common than in the population at large.1,3 Yet these factors alone may not fully account for the increased risk in these patients, because often, younger patients without traditional risk factors seem to be at the greater risk of such events.3 Moreover, previous studies have shown that pregnancy complications, such as those resulting in a small-for-gestational-age infants, may increase the later risk of cardiovascular mortality in lupus patients.4

Amanda Eudy, PhD, is an assistant professor of medicine at Duke University, Durham, N.C., and first author of the recent study. “It’s an important topic for the health of the infant and the impact of the pregnancy,” she explains, noting the impetus for the study.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“It also has long-term implications for the overall health of the mother. Since cardiovascular events are more prevalent in lupus patients compared to the general population anyway, perhaps improving cardiovascular health at an earlier age—during those reproductive years, could have a long-term impact on improving their health overall.”

Study Design

For the study, Dr. Eudy and colleagues used data from the Hopkins Lupus Pregnancy Cohort, which began to study pregnant lupus patients as a prospective cohort in 1987. Ultimately, 309 lupus pregnancies were analyzed (from 261 lupus patients). The research team focused its efforts on the cardiovascular health impact goals elucidated by the American Heart Association (AHA).5 Data for three of these factors were available: total cholesterol, blood pressure and body mass index (BMI). Data were collected from the year prior to conception or from the first trimester if preconception data were not available.

Poor cholesterol health was defined as greater than or equal to 240 mg/dL; intermediate health as 200–239 mg/dL or treated to goal; ideal health as less than 200 mg/dL. For blood pressure, poor health was defined as systolic greater than or equal to 140 mmHg or diastolic greater than or equal to 90 mmHg; intermediate health as between 120 and 139 mmHg systolic or between 80 and 89 mmHg diastolic or treated to goal; ideal health as less than 120 mmHg systolic and less than 80 mmHg diastolic. For BMI, obese was defined as greater than or equal to 30 kg/m2; overweight as between 25 and 30 kg/m2; ideal as less than 25 kg/m2.

To account for confounding variables, Dr. Eudy and colleagues included covariates in their analysis, including race, age, education, disease duration, medication use, renal involvement and organ damage at conception. Using ANOVA, Fisher’s exact test and regression models, the researchers analyzed differences in the prevalence of preterm birth, small-for-gestational-age infants, mean gestational age and mean birth weight for gestational age z-score.

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsResearch RheumSystemic Lupus Erythematosus Tagged with:cardiovascularpregnancy

Related Articles

    A Better Family Plan

    October 1, 2007

    How to minimize the risks of pregnancy for women with SLE

    Rheumatologists Should Discuss with Patients Use of Immunomodulatory Agents During Pregnancy

    November 16, 2016

    The decision to continue or discontinue immunomodulatory medications during pregnancy is a difficult one for both patients and physicians. On the one hand, when left untreated, rheumatic conditions can cause harm to an unborn child, as well as to the pregnant mother. On the other hand, medications can be harmful to a developing fetus. In…

    Treat to Target: Rheumatoid Arthritis in Pregnant Patients

    October 1, 2012

    A treat-to-target approach to managing rheumatoid arthritis can work even in pregnant women

    AndreyCherkasov / Shutterstock.com

    Rheumatic Disease Does Not Preclude Pregnancy

    November 9, 2017

    Preconception planning is essential to help women with autoimmune disease have optimal pregnancy outcomes. Unplanned pregnancy can also negatively impact disease course in some patients. Yet many rheumatologic patients of childbearing age do not receive adequate contraception or prepregnancy education and counseling. Rheumatologists must work collaboratively with other healthcare providers to make sure rheumatic patients…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences